Novel Biomarkers of Gastrointestinal Cancer

• Andere auteurs: Shimura, Takaya (Redacteur)
• Formaat: Elektronisch Hoofdstuk
• Taal: Engels
• Gepubliceerd in: Basel MDPI - Multidisciplinary Digital Publishing Institute 2022
• Onderwerpen: Oncology; colorectal cancer; advanced adenoma; screening; stool; mRNA; n/a; cancer screening; cirrhosis; AFP; machine learning; MALDI-TOF; proteomics; CXCR4; prognosis; overall survival; rectal cancer; neoadjuvant chemoradiation; mouse model; biomarkers; urokinase plasminogen activator (uPA); urokinase plasminogen activator receptor (uPAR); plasminogen activator inhibitor type 1 (PAI-1); circulating tumour cell (CTC); gastric cancer; oesophageal cancer; serine proteases; tumour microenvironment; serpins; biomarker; chemoresistance; liquid biopsy; microRNA; long non-coding RNA; colorectal neoplasms; cancer screening tests; early detection of cancer; precision medicine; unfolded protein; hepatocellular cancer; GSVA; unfolded protein score; epigenetic regulation genes; somatic mutations; molecular genetic markers; extracellular vesicles; microbiome; 16S rRNA amplicon; metagenomics; liver fibrosis; hepatocellular carcinoma; recurrence; SHG/TPEF microscopy; artificial intelligence; advanced gastric cancer; targeted therapy; urinary miRNA; miR-129-1-3p; miR-566
• Online toegang: DOAB: download the publication; DOAB: description of the publication

Gastrointestinal (GI) cancer is a major cause of morbidity and mortality in the world. Since early diagnosis and optimal treatment selection are crucial to improving the prognosis of these diseases, the discovery of useful biomarkers has the potential to greatly reduce their burden. Recent technical...